Author

Stéphanie Gachet

Centre National de la Recherche ScientifiqueORCID 0000-0003-0491-9949Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

André BarucheliD· 1 shared Didier BussoiD· 1 shared Emmanuelle ClappieriD· 1 shared François Sigaux· 1 shared Françoise PflumioiD· 1 shared Guillaume Piton· 1 shared Hervé DombretiD· 1 shared Hugo BergugnatiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

André BaruchelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 16, 2026

In vivo isogenic modelling unveils TP53-associated relapse trajectories in T-cell acute lymphoblastic leukemia

Stéphanie Gachet, Samuel Quentin, Lucie Hernandez…·Jean Soulier

This study uses patient-derived xenografts to identify TP53-associated relapse mechanisms in T-ALL, showing relapse phenotypes linked to OXPHOS metabolism and MYC signaling.

DOI 10.64898/2026.01.19.700255

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 13, 2026

Transplantation in neonate mouse recipients enhances umbilical cord blood CD34+ cells permissiveness to ETO2::GLIS2-driven transformation

Klaudia Galant, Vilma Barroca, Saiyirami Devanand…·Françoise Pflumio

This study shows that neonatal mouse recipients are more permissive than adult mice for ETO2::GLIS2-driven leukemogenesis from human cord blood CD34+ cells.

DOI 10.64898/2026.01.12.698953

mousehuman

𝕏 PostBluesky